AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

RecruitingPhase 3Ages 1 Year - 18 YearsAllEli Lilly and Company
💬

In plain words

What the trial is, and whether it could suit you

The reason for this study is to see if the study drug baricitinib is safe and effective in the treatment of JIA in participants ages 1 to 17. This study is for participants that have been enrolled in studies I4V-MC-JAHV (NCT03773978) or I4V-MC-JAHU.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Participants must have completed a previous study of baricitinib for the treatment of JIA. Exclusion Criteria: * Participants must not have had a permanent discontinuation of baricitinib in the prior study. * Participants must have not developed an allergy to baricitinib.
💊

What it tests

  • Baricitinib
📍

Where

78 sites
Instituto CAICI SRL
Rosario, Argentina
Centro de Investigaciones Médicas Tucuman
SAN M. de Tucuman, Argentina
Royal Children's Hospital
Melbourne, Australia
Perth Children's Hospital
Perth, Australia
The Children's Hospital at Westmead
Westmead, Australia
Landeskrankenhaus Bregenz
Bregenz, Austria
Cliniques universitaires Saint-Luc
Brussels, Belgium
UZ Gent
Ghent, Belgium

…and 70 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy